RCM
GRTX

RA Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

RA Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-825,118
Closed -$7.46M – 88
2020
Q3 		$7.46M Hold
825,118
– – 0.14% 63
2020
Q2 		$5.89M Sell
825,118
-67,997
-8% -$722K 0.11% 52
2020
Q1 		$8.48M Sell
893,115
-161,063
-15% -$2.08M 0.27% 40
2019
Q4 		$13.9M Buy
+1,054,178
New +$12.9M 0.42% 30

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RA Capital Management's GRTX Position: Q4 2020 in Review

RA Capital Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2020, closing a stake of 825,118 shares — an estimated $7.46M sold.

RA Capital Management first reported a position in GRTX in Q4 2019 and held it in 4 quarters. The position peaked at $13.9M in Q4 2019. 51 funds tracked by Wall St. Rank hold GRTX as of Q4 2020.

  • RA Capital Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • RA Capital Management sold 825,118 Galera Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $7.46M.
  • RA Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • RA Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $13.9M in Q4 2019.
  • 51 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2020.

Based on RA Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.